Inbiomed

Inbiomed (Instituto de Investigación Biomédica de México) is a leading Mexican Clinical Research Organization (CRO) providing comprehensive services to the pharmaceutical and biotechnology industries. Founded in 1995, the company specializes in the management of Phase I-IV clinical trials, bioequivalence studies, and regulatory affairs within the Latin American market. Inbiomed operates a state-of-the-art clinical unit and analytical laboratories, offering expertise in a wide range of therapeutic areas including oncology, infectious diseases, and metabolic disorders. The company is recognized for its deep understanding of the Mexican regulatory landscape and serves as a critical partner for international sponsors seeking to conduct high-quality clinical research in the region.